BioMed Research International / 2009 / Article / Tab 4

Research Article

Variable Increased Expression of Program Death-1 and Program Death-1 Ligands on Peripheral Mononuclear Cells Is Not Impaired in Patients with Systemic Lupus Erythematosus

Table 4

Enhancement on IL-10 production by blockage of PD-1 or PD-1 ligands.

Blocking AbsNormal ( ) Mean ± SD (%)*SLE ( ) Mean ± SD (%) value

Anti-PD-1126 ± 23076 ± 149.724
Anti-PDL197 ± 316132 ± 232.943
Anti-PDL2106 ± 43173 ± 72.622
Anti-PDL1+Anti-PDL2112 ± 349104 ± 137.622

* These percentages refer to change over baseline of IgG-treated PBMCs.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.